HomeTGTX • NASDAQ
add
TG Therapeutics Inc common stock
Previous close
$16.51
Day range
$16.42 - $17.09
Year range
$6.46 - $35.22
Market cap
2.62B USD
Avg Volume
3.54M
P/E ratio
76.96
Dividend yield
-
Primary exchange
NASDAQ
Top news
Q1 earnings report for TG Therapeutics, Inc
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 63.47M | 713.46% |
Operating expense | 67.30M | 53.18% |
Net income | -10.71M | 72.71% |
Net profit margin | -16.87 | 96.64% |
Earnings per share | -0.07 | 75.00% |
EBITDA | -9.22M | 75.04% |
Effective tax rate | -0.27% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 217.51M | 55.69% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 160.50M | — |
Shares outstanding | 144.78M | — |
Price to book | 14.61 | — |
Return on assets | — | — |
Return on capital | -8.53% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -10.71M | 72.71% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1993
Headquarters
Website
Employees
264